$0.94
0.06 (+6.83%)
GenVec, Inc. (GNVC)
CAPS Rating:
A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.
Fool.com
The World's Greatest Investing Community
A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK